Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction
James O. Price
2 Pathology, Department of Veterans Affairs Medical Center and Vanderbilt University, and
3 The Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
Search for more papers by this authorSanford B. Krantz
Departments of 1 Medicine and
3 The Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
Search for more papers by this authorJames O. Price
2 Pathology, Department of Veterans Affairs Medical Center and Vanderbilt University, and
3 The Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
Search for more papers by this authorSanford B. Krantz
Departments of 1 Medicine and
3 The Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
Search for more papers by this authorAbstract
Summary. Tumor necrosis factor α (TNFα) potently inhibits the in vitro growth of highly purified human d-6 erythroid colony forming cells (ECFC). Unlike the inhibitory effect of TNFα on other cells, including more immature ECFC, this antiproliferative effect of TNFα is not related to apoptosis because the d-6 cell descendants were morphologically normal, without apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay and without caspase activation by Western blots after TNFα treatment. TNFα did not appear to affect the cell cycle distribution, but the cell cycle duration was significantly longer in TNFα-treated cells. DNA synthesis was also significantly reduced by TNFα. Studies of various proteins that regulate the cell cycle showed that cyclin-dependent kinase 6 (CDK6) protein and mRNA levels were concomitantly decreased in the presence of TNFα, suggesting that inhibition of cell growth was related to reduced CDK6. To evaluate this, the CDK6 gene was transferred into ECFC using green fluorescence protein-retrovirus-mediated gene transfer. The results showed that the level of cell growth produced by TNFα was increased by 30% when the cells were transfected with CDK6. Therefore, the modification of cell cycle progression in the presence of TNFα through a reduction of CDK6 is an important mechanism in the TNFα inhibition of human ECFC expansion.
References
- Aggarwal, B.B. (2000) Tumor necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB. Annals of the Rheumatic Diseases, 59, i6 – i16.
- Bang, S., Jeong, E.-J., Kim, I.-K., Jung, Y.-K. & Kim, K.-S. (2000) Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. Journal of Biological Chemistry, 275, 36217 – 36222.
- Caux, C., Saeland, S., Favre, C., Duvert, V., Mannoni, P. & Banchereau, J. (1990) Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte–macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood, 75, 2292 – 2298.
- Dai, C.-H. & Krantz, S.B. (2001) Tumor necrosis factor-alpha growth inhibition of human erythroid progenitor cells is associated with downregulation of CDK6. Experimental Hematology, 29(Suppl.), 47.
- Dai, C.-H., Price, J.O., Brunner, T. & Krantz, S.B. (1998) Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood, 91, 1235 – 1242.
- Dai, M.S., Heinrich, M.C., Broxmeyer, H.E. & Lu, L. (2000) Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors. Cytokines, Cellular and Molecular Therapy, 6, 1 – 8.
- Declercq, W., Denecker, G., Fiers, W. & Vandenabeele, P. (1998) Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. Journal of Immunology, 161, 390 – 399.
- Ferguson, K.L., Callaghan, S.M., O'Hare, M.J., Park, D.S. & Slack, R.S. (2000) The Rb–CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation. Journal of Biological Chemistry, 275, 33593 – 33600.
- Fraisse, C.S., Rincheval, V., Risler, Y., Mignotte, B. & Vayssiere, J.L. (1998) TNF-α activates at least two apoptotic signaling cascades. Oncogene, 17, 1639 – 1651.
- Hanenberg, H., Hashino, K., Konishi, H., Hock, R.A., Kato, I. & Willliams, D.A. (1997) Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoitic cells. Human Gene Therapy, 8, 2193 – 2206.
- Heuvel, S. & Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science, 262, 2050 – 2054.
- Higuchi, M., Proske, R. & Yeh, E.T. (1998) Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene, 17, 2515 – 2524.
- Hu, X., Bryington, M., Fisher, A.B., Liang, X., Zhang, X., Cui, D., Datta, I. & Zuckerman, K.S. (2002) Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. Journal of Biological Chemistry, 277, 16528 – 16537.
- Israels, E.D. & Israels, L.G. (2001) The cell cycle. Stem Cells, 19, 88 – 91.
- Kobayashi, N., Takada, Y., Hachiya, M., Ando, K., Nakajima, N. & Akashi, M. (2000) TNF-α induced p21WAF1 but not bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization. Cytokine, 12, 1745 – 1754.
- Leong, K.G. & Karsan, A. (2000) Signaling pathways mediated by tumor necrosis factor α. Histology and Histopathology, 15, 1303 – 1325.
- Liu, R.Y., Fan, C., Mitchell, S., Chen, Q., Wu, J. & Zuckerman, K.S. (1998) The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-α to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e. Cancer Research, 58, 2217 – 2223.
- Lundberg, A.S. & Weinberg, R.A. (1999) Control of the cell cycle and apoptosis. European Journal of Cancer, 35, 531 – 539.
- McDermott, M. (2001) TNF and TNFR biology in health and disease. Cellular and Molecular Biology (Noisy-le-Grand, France), 47, 619 – 635.
- Means, Jr, R.T. & Krantz, S.B. (1993) Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. Journal of Clinical Investigation, 91, 416 – 419.
- Means, Jr, R.T., Dessypris, E.N. & Krantz, S.B. (1990) Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. Journal of Clinical Investigation, 86, 538 – 541.
- Newton, R.C. & Decicco, C.P. (1999) Therapeutic potential and strategies for inhibiting tumor necrosis factor-α. Journal of Medicinal Chemistry, 42, 2295 – 2314.
- Pennica, D., Nedwin, G.E., Hayflick, J.S., Seeburg, P.H., Derynck, R., Palladino, M.A., Kohr, W.J., Aggarwal, B.B. & Goeddel, D.V. (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature, 312, 724 – 729.
-
Piguet, P.F.,
Vesin, C.,
Guo, J.,
Donati, Y. &
Barazzone, C. (1998) TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53.
European Journal of Immunology, 28, 3499
–
3505.
10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- Planas-Silva, M.D. & Weinberg, R.A. (1997) The restriction point and control of cell proliferation. Current Opinion in Cell Biology, 9, 768 – 772.
- Rath, P.C. & Aggarwal, B.B. (1999) TNF-induced signaling in apoptosis. Journal of Clinical Immunology, 19, 350 – 364.
- Rusten, L.S. & Jacobsen, S.E.W. (1995) Tumor necrosis factor (TNF)-α directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood, 85, 989 – 996.
- Sawada, K., Krantz, S.B., Kans, J.S., Dessypris, E.N., Sawyer, S., Glick, A.D. & Civin, C.I. (1987) Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. Journal of Clinical Investigation, 80, 357 – 366.
- Sherr, C.J. & Roberts, J.M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development, 13, 1501 – 1512.
- Shields, L.E., Kiem, H.-P. & Andrews, R.G. (2000) Highly efficient gene transfer into preterm CD34+ hematopoietic progenitor cells. American Journal of Obstetrics and Gynecology, 183, 732 – 737.
- Slowik, M.R., Min, W., Ardito, T., Karsan, A., Kashgarian, M. & Pober, J.S. (1997) Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Laboratory Investigation, 77, 257 – 267.
- Tschopp, J., Martinon, F. & Hofmann, K. (1999) Silencing the death receptors. Current Biology, 9, r381 – r384.
- Vanderlaan, M., Watkins, B., Thomas, C., Dolbeare, F. & Stanker, L. (1986) Improved high-affinity monoclonal antibody to iododeoxyuridine. Cytometry, 7, 499 – 507.
- Wallach, D., Varfolomeev, E.E., Malinin, N.J., Goltsev, Y.V., Kovalenko, A.V. & Boldin, M.P. (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annual Review of Immunology, 17, 331 – 367.
- Wognum, A.W., Visser, T.P., Peters, K., Bierhuizen, M.F.A. & Wagemaker, G. (2000) Stimulation of mouse bone marrow cells with kit ligand, FLT3 ligand, and thrombopoietin leads to efficient retrovirus-mediated gene transfer to stem cells, whereas interleukin 3 and interleukin 11 reduce transduction of short- and long-term repopulating cells. Human Gene Therapy, 11, 2129 – 2141.
- Wright, N.A. & Appleton, D.R. (1980) The metaphase arrest technique: a critical review. Cell and Tissue Kinetics, 13, 643 – 664.
- Yu, C., Takeda, M. & Soliven, B. (2000) Regulation of cell cycle proteins by TNF-α and TNF-β in cells of oligodendroglial lineage. Journal of Neuroimmunology, 108, 2 – 10.